Stock A078650 G9PHARMA CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News G9pharma co., LTD

Equities

A078650

KR7078650009

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023
CI
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
G9pharma co., LTD Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
G9pharma co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2022
CI
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
G9pharma co., LTD Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
G9pharma co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2021
CI
G9pharma co., LTD cancelled the transaction announced on November 26, 2021
CI
G9pharma co., LTD announced that it has received KRW 9.9999984 billion in funding from Meritz Securities Co., Ltd., Investment Arm, Cypress Partners Co., Ltd.
CI
G9pharma co., LTD announced that it has received KRW 5.999999573 billion in funding from Meritz Securities Co., Ltd., Investment Arm
CI
G9pharma co., LTD announced that it expects to receive KRW 1.5 billion in funding from Cypress Partners Co., Ltd.
CI
G9pharma co., LTD announced that it has received KRW 9.99999775 billion in funding from Meritz Securities Co., Ltd., Investment Arm
CI
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Mosaic Ventures, Luck & Trust Co., Ltd., Han International Co., Ltd., Hannam World and Medi Forum Co.,Ltd. completed the acquisition of 20.9% stake in Kolen Co., Ltd from Biolog Device Co., Ltd..
CI
G9pharma co., LTD announced that it expects to receive KRW 17.99999925 billion in funding from Meritz Securities Co., Ltd., Investment Arm, Cypress Partners Co., Ltd.
CI
Mosaic Ventures, Luck & Trust Co., Ltd., Han International Co., Ltd., Hannam World and Medi Forum Co.,Ltd. signed an agreement to acquire 20.9% stake in Kolen Co., Ltd from Biolog Device Co., Ltd. for KRW 15.5 billion.
CI
G9pharma co., LTD announced that it expects to receive KRW 25.999999573 billion in funding from Meritz Securities Co., Ltd., Investment Arm
CI
1EVOLUTION Marketing Research Inc. cancelled the acquisition of 99.99% stake in KOLEN PHILIPPINES INC from Kolen Co., Ltd.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A078650 Stock
  4. News G9pharma co., LTD